JP Morgan upgrades Cinemark on improving 2026-27 film slate visibility

Investing.com
04-12

Investing.com -- JP Morgan upgraded Cinemark Holdings (NYSE:CNK) to “Overweight” from “Neutral” on growing confidence in the 2026-2027 film pipeline and reduced box office expectations for 2025 that now better align with the bank’s forecasts.

JP Morgan also noted that market expectations have adjusted for potential share loss as theater capacity tightens, a dynamic it had previously flagged as a risk.

On the positive side, visibility into future supply has improved meaningfully, particularly following updates from CinemaCon.

Amazon (NASDAQ:AMZN) MGM’s commitment to produce 15 theatrical films annually by 2027 offers a replacement for lost 20th Century Fox output, which has weighed on the industry since Disney’s 2017 acquisition, the bank said.

Channel checks with entertainment executives further support a healthy pipeline of upcoming projects.

JP Morgan also pointed to Cinemark’s limited economic sensitivity, noting that theater attendance tends to correlate more with film quality than macroeconomic conditions.

As an example, the firm cited Minecraft’s $162 million opening weekend, which came despite broader market volatility.

While concerns remain around shortened theatrical windows and their effect on mid-budget films, the bank said it was encouraged by studios’ efforts to simplify and extend exclusivity periods.


It set a December 2025 price target of $34, valuing the stock at the midpoint of a 6.5x–8.5x range and incorporating potential dilution or payout from convertibles.

JP Morgan maintained a Neutral rating on IMAX (NYSE:IMAX) citing risks tied to China and exhibitor capital spending.

Related articles

Volkswagen's Scania buys bankrupt Northvolt's heavy industry battery packs unit

GM halts electric van production in Ontario, lays off 1,200

Mega-Cap Stock Movers Led by Avago, Visa on Friday's Trading Session

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10